Staff and funding cuts to the NIH, FDA and USAID could have downstream implications for R&D in the pharma industry, experts ...

Brand.com’s are connecting HCPs to information, with fewer hoops to jump through, courtesy of new digital tools promising to ...

E.P.A.: Lee Zeldin, the administrator of the Environmental Protection Agency, reframed the purpose of the E.P.A ., saying his ...

Taoiseach Micheál Martin met US president Donald Trump yesterday in a hotly anticipated meeting as part of St Patrick’s Day ...

Explore why Recursion Pharmaceuticals' AI-driven drug discovery faces challenges in revenue growth, governance, and investor ...

U.S. drugmakers Johnson & Johnson and Eli Lilly increased spending on security for their top executives in 2024, citing ...

Treatments for autoimmune diseases and those in orphan markets are on the up and up, as are drugmakers’ first launches, ...

Glenmark and Alkem Labs launched the generic version as well as its Fixed Dose Combination (FDCs) of Empagliflozin in India.

The BSE Sensex swung in a near 800-point range amid buying support in private banking shares, and weakness in IT stocks on Wednesday. Broader indices dipped around 0.5%.

The US pharmaceutical sector is experiencing a distinct trend never seen before with large American pharma companies continually looking for medicines in China.

Seeking more efficient drug development, pharmaceutical giants and startups are encouraging AI fluency and in some cases ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...